COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT02547922
Brief Title: Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis (TULIP-LN1)

First Submitted : August 31, 2015
First Submitted that Met QC Criteria : September 10, 2015
First Posted : September 14, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : April 10, 2020
Last Update Posted : April 14, 2020